OTCMKTS:ILIU

(ILIU) (ILIU) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0040
$0.0045
50-Day Range
N/A
52-Week Range
$0.00
$0.14
Volume
26,317 shs
Average Volume
91,936 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (ILIU)

Interleukin Genetics, Inc. develops and markets genetic tests for chronic diseases and health-related conditions. The Company operates through the genetic test business segment. The Company's products include PerioPredict genetic test and Inherent Health line of genetic tests. PerioPredict is a genetic risk test that analyzes genetic variations associated with inflammation and identifies individuals with a life-long predisposition to over-produce inflammation. PerioPredict identifies specific polymorphisms (genetic variations) in genes that regulate the production of interleukin-1 cytokines. PerioPredict identifies adults at increased risk for severe periodontal disease. The Company markets additional genetic tests through its Inherent Heath brand. Its additional genetic tests include weight management genetic test, bone health genetic test, heart health genetic test, nutritional needs genetic test and wellness select genetic test.

ILIU Stock News Headlines

Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
See More Headlines
Receive ILIU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ILIU) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/12/2017
Today
4/24/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:ILIU
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Barry Kallander
    President, Treasurer, Secretary, Director
  • Stephan Toutain (Age 50)
    Chief Commercial Officer
  • Dayton C. Misfeldt (Age 43)
    Independent Director

ILIU Stock Analysis - Frequently Asked Questions

How were (ILIU)'s earnings last quarter?

(ILIU) (OTCMKTS:ILIU) announced its earnings results on Friday, May, 12th. The company reported ($0.01) EPS for the quarter. The business earned $0.20 million during the quarter.

What other stocks do shareholders of (ILIU) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ILIU) investors own include Capricor Therapeutics (CAPR), Alibaba Group (BABA), Acceleware (AXE), Abraxas Petroleum (AXAS), Yamana Gold (AUY), Atlas Energy Group (ATLS), Autohome (ATHM), Arotech (ARTX), Alpha Natural Resources (ANRZQ).

This page (OTCMKTS:ILIU) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners